Renal transplantation in the elderly: a long‐term, single‐centre experience

Saudan, Patrick; Berney, Thierry; Leski, M; Morel, Philippe; Bolle, J; Martin, Pierre‐Yves

doi:10.1093/ndt/16.4.824

Cited by 48 publications

(40 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Donor age had little influence on graft survival in the older recipient group and no influence on patient survival. We conclude, like others, 11 that donor age is less important in elderly patients: the potentially short graft survival does not affect patient survival.…”

Section: Discussionsupporting

confidence: 82%

“…11 There are, however, some reports where aged recipients had a rejection rate higher than younger controls, ranging from 40% to 70%. 13,14 This can be partially explained, in these studies, by worse compatibility in terms of HLA mismatches presented by the elderly subset of patients.…”

Section: Discussionmentioning

confidence: 98%

“…Some authors have reported these fact, 17 and described protocols to evaluate and correct cardiovascular risk factors, 5,11 seeking to minimize the main cause of death in this population.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Do Elderly Patients Deserve a Kidney Graft?

Nunes

Mota

Parada

et al. 2005

Transplantation Proceedings

View full text Add to dashboard Cite

Purpose. Compare renal transplant long-term outcomes among recipients aged 60 years or older with those in younger patients. Patients and methods. We analyzed 103 transplants in recipients above 60 years of age for the influence of key factors related to the graft and patient. The results were compared with 1060 transplant recipients aged 18 to 59 years. Results. The mean ages were 62.93 and 40.35 years for the older and younger group. The older group showed a higher prevalence of obesity and unknown etiologies for the end-stage renal disease. Important comorbidity was significantly more frequent among recipients aged more than 60 years, mainly of a cardiovascular nature (56% vs 18.5%). Donor age (39.75 vs 31.59 years), cold ischemia time (22.43 vs 20.49 hours) and human leukocyte antigen compatibilities (2.59 vs 2.36) were significantly greater in the older subset. After a mean follow-up of 4.72 and 6.07 years for the older versus younger group, we found no differences in initial graft function, acute rejection rate, and serum creatinine/clearance. Patient and graft survivals at 1, 5, and 10 years were lower among the 60ϩ group. There were no differences in graft survival censored for death with a functioning graft, namely, 95.1%, 89.4%, and 81.2% for the 60ϩ cohort. The main cause of graft loss in the older group was death with a functioning graft. Conclusion. Renal transplantation should be considered for selected patients older than 60 years. Despite a shorter life expectancy, they benefit from it similar to younger recipients. T HE INCIDENCE OF end-stage renal disease (ESRD)increases with advancing age. Patients older than 60 years represent between 53% and 66% of the population requiring renal replacement therapies.1 Therapy for ESRD in the elderly is characterized by tremendous challenges, raising medical, ethical, and socioeconomic concerns. Hemodialysis, the most frequently used renal replacement modality in these patients, is associated with significant morbidity, mortality, and a poor quality of life.2,3 The great organ shortage, higher comorbidity rate, and shorter life expectancy make the allocation of kidneys to this population controversial.Nevertheless, transplantation is the gold standard treatment for ESRD patients. With immunosuppression based upon calcineurin inhibitors, it has become a feasible alternative for the elderly population. 4 -7 Compared with hemodialysis, renal transplantation is associated with a 61% decrease in the long-term risk of death and an additional 4-year life expectancy for patients over 60 years. 4 In this retrospective study, we report a single-center, long-term follow-up of kidney transplants in patients above

show abstract

Section: Discussionsupporting

confidence: 82%

Section: Discussionmentioning

confidence: 98%

See 1 more Smart Citation

Do Elderly Patients Deserve a Kidney Graft?

Nunes

Mota

Parada

et al. 2005

Transplantation Proceedings

View full text Add to dashboard Cite

show abstract

“…12 Some authors have argued that the better results reported in some series of older recipients may be due to less acute rejection in elderly recipients. 7,13 Consistent with these observations, we also found a significantly lower rejection rate among the older group, which may also contribute to the survival results.…”

Section: Discussionsupporting

confidence: 88%

Renal Transplantation in Patients Over 60 Years of Age: A Single-Center Experience

Pedroso

Martins

Fonseca

et al. 2006

Transplantation Proceedings

View full text Add to dashboard Cite

The prevalence of end-stage renal disease (ESRD) increases with advancing age. In most countries renal transplant recipients are getting older, too. Transplantation must be considered for ESRD patients older than 60 years; however, there are few data regarding outcomes in this population. We retrospectively reviewed the clinical course of recipients aged Ն60 years (n ϭ 43) who underwent primary or repeated grafts from August 1988 to December 2004. We then compared recipient and donor characteristics as well as graft and patient survivals with recipients aged 18 to 59 years (n ϭ 1058) who were transplanted during the same time. Donor age tended to be higher among the oldest recipient group (P Ͻ .001). Mean follow-up was significantly shorter in the group aged Ն60 years (P Ͻ .001), as our institution only recently has frequently accepted patients Ն60 years. Older recipients showed more frequent delayed graft function (P ϭ .007), longer initial hospitalization (P ϭ .005), and a significantly lower incidence of posttransplant acute rejection episodes (P ϭ .015). Patient (P ϭ .057), graft (P ϭ .407), and death-censored graft (P ϭ .649) survivals were not different between the two groups. Seven recipients aged Ն60 years died; the main cause of which was cardiovascular in origin. The loss of organs (n ϭ 11) in the older patients was mainly due to death with a functioning kidney (54.5%). Our results confirm that renal transplant must be considered in selected patients older than 60 years as patient and graft survivals are similar to those of younger patients. E LDERLY PATIENTS are the fastest growing population in dialysis programs. 1 Hemodialysis is the more commonly used modality, although it is associated with significant morbidity, mortality, and a poor quality of life. The prevalence of end-stage renal disease (ESRD) increases with advancing age. In most countries, renal transplant recipients are also getting older. In the precyclosporine era the unsatisfactory results of grafting in the elderly lead to the exclusion of patients more than 60 years of age due to higher risks for patient death and graft loss. 2 With widespread use of calcineurin inhibitors, the age limit for transplantation has expanded. Today, transplantation is considered the best treatment option for ESRD patients regardless of age when compared with dialysis. [3][4][5] With the development of new immunosuppressive alternatives, transplantation is safe and successful. It should be considered an alternative to dialysis even among older patients. Older ESRD patient survival after transplantation is higher than on the waiting list. [3][4][5] However, the organ donor shortage makes clinicians reluctant to transplant kidneys into older patients. Controversy has emerged regarding the appropriateness of transplantation in this patient group with a shortened life expectancy. Numerous studies have reported worse patient and graft survivals in older patients compared with younger patients, while other analyses did not find any difference. 6 -9 The...

show abstract

“…Wolfe et al [29] compared the survival of primary deceased donor transplant recipients with other dialysis patients and found that among renal transplant recipients patients aged 60-74 years, the cumulative survival rate improved after the first year post-transplantation. More recent studies indicate that in elderly ESRD patients, survival at 1, 5, and 10 years is approximately 80% to 90%, 70%, and 50% respectively [38][39][40][41][42][43][44][45][46]. In the United States there are currently over 16,000 ESRD patients older than 65 years waiting for a kidney transplantation, representing 18% of all listed candidates [1].…”

mentioning

confidence: 99%